| Vicarious Surgical Announces Planned Retirement of Chief Operating Officer |
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced Chief Operating Officer (COO) John Mazzola will retire, effective April 1, 2025, after nearly 40 years in healthcare manufacturing, supply chain and quality control. Mr. Mazzola will continue to serve as COO until the effective date, at which time his respons. |
businesswire.com |
2025-02-18 18:05:00 |
Czytaj oryginał (ang.) |
| Vicarious Surgical Announces Departure of Chief Financial Officer |
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced the pending departure of William Kelly, its Chief Financial Officer (CFO), to pursue other career opportunities, after nearly four years of dedicated service with the Company. Mr. Kelly has served as Vicarious Surgical's CFO since January 2021. He will assist. |
businesswire.com |
2024-12-06 18:05:00 |
Czytaj oryginał (ang.) |
| Vicarious Surgical Inc. (RBOT) Q3 2024 Earnings Call Transcript |
Vicarious Surgical Inc. (NYSE:RBOT ) Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ET Company Participants Kaitlyn Brosco – Director-Investor Relations Adam Sachs – Co-Founder and Chief Executive Officer Bill Kelly – Chief Financial Officer Conference Call Participants Adam Maeder – Piper Sandler Operator Hello, everyone, and welcome to Vicarious Surgical's Third Quarter 2024 Earnings Call. My name is Lydia and I'll be your operator today. |
seekingalpha.com |
2024-11-13 00:02:45 |
Czytaj oryginał (ang.) |
| Vicarious Surgical to Report Third Quarter 2024 Financial Results on November 12, 2024 |
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced it will report financial results for the third quarter ended September 30, 2024 after the market closes on Tuesday, November 12, 2024. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time. Investors interested in li. |
businesswire.com |
2024-10-29 10:30:00 |
Czytaj oryginał (ang.) |
| Vicarious Surgical Inc (RBOT) Q2 2024 Earnings Call Transcript |
Vicarious Surgical Inc (NYSE:RBOT ) Q2 2024 Results Conference Call August 12, 2024 4:30 PM ET Company Participants Kaitlyn Brosco - IR Bill Kelly - CFO & Treasurer Adam Sachs - Co-Founder, CEO & Director Conference Call Participants Eric Anderson - TD Cowen Andrew Ranieri - Morgan Stanley Ryan Zimmerman - BTIG Operator Good afternoon. Thank you for attending the Vicarious Surgical's 2024 Second Quarter Earnings Call. |
seekingalpha.com |
2024-08-12 23:40:29 |
Czytaj oryginał (ang.) |
| Vicarious Surgical (RBOT) Partners LSU Health New Orleans |
Vicarious Surgical (RBOT) teams up with LSU Health New Orleans to advance its V1.0 surgical robot. It aims to file for FDA approval by 2026. |
zacks.com |
2024-08-08 16:11:06 |
Czytaj oryginał (ang.) |
| Vicarious Surgical Announces Reverse Stock Split |
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives through the transformation of surgical robotics, today announced it will effect a 1-for-30 reverse stock split of the Company's issued and outstanding Class A common stock, par value $0.0001 per share, and Class B common stock, par value $0.0001 per share. The reverse stock split was approved by Vicarious S. |
businesswire.com |
2024-06-10 20:15:00 |
Czytaj oryginał (ang.) |
| RBOT Stock Earnings: Vicarious Surgical Meets EPS for Q1 2024 |
Vicarious Surgical (NYSE: RBOT ) just reported results for the first quarter of 2024. Vicarious Surgical reported earnings per share of -9 cents. |
investorplace.com |
2024-04-30 00:54:59 |
Czytaj oryginał (ang.) |
| Vicarious Surgical Inc. (RBOT) Q1 2024 Earnings Call Transcript |
Vicarious Surgical Inc. (NYSE:RBOT ) Q1 2024 Earnings Conference Call April 29, 2024 4:30 PM ET Company Participants Kaitlyn Brosco - Head, Investor Relations Adam Sachs - Co-Founder and CEO Bill Kelly - Chief Financial Officer Randy Clark - President Conference Call Participants Ryan Zimmerman - BTIG Adam Maeder - Piper Sandler Josh Jennings - TD Cowen Operator Hello. And welcome to Vicarious Surgical's 2024 First Quarter Earnings Call. |
seekingalpha.com |
2024-04-30 00:16:02 |
Czytaj oryginał (ang.) |
| Vicarious Surgical Reports First Quarter 2024 Financial Results |
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives through the transformation of surgical robotics, today announced financial results for the quarter ended March 31, 2024. Management will host a corresponding conference call at 4:30 p.m. ET today, April 29, 2024. “I'm proud to report a productive start to 2024 as we advance our mission to improve lives by t. |
businesswire.com |
2024-04-29 20:05:00 |
Czytaj oryginał (ang.) |
| Vicarious Surgical to Report First Quarter 2024 Financial Results on April 29, 2024 |
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced it will report financial results for the first quarter ended March 31, 2024 after the market closes on Monday, April 29, 2024. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time. Investors interested in l. |
businesswire.com |
2024-04-08 20:30:00 |
Czytaj oryginał (ang.) |
| Vicarious Surgical Inc. (RBOT) Q4 2023 Earnings Call Transcript |
Vicarious Surgical Inc. (NYSE:RBOT ) Q4 2023 Earnings Conference Call March 4, 2024 4:30 PM ET Company Participants Kaitlyn Brosco - IR Adam Sachs - CEO William Kelly - CFO Conference Call Participants Ryan Zimmerman - BTIG Operator Good afternoon, and welcome to Vicarious Surgical's Fourth Quarter 2023 Earnings Conference Call. My name is Matt, and I'll be your operator for today's call. |
seekingalpha.com |
2024-03-04 19:32:19 |
Czytaj oryginał (ang.) |
| Vicarious Surgical Reports Fourth Quarter and Full Year 2023 Financial Results |
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced financial results for the quarter and full year ended December 31, 2023. Management will host a corresponding conference call at 4:30 p.m. ET today, March 4, 2024. “We made meaningful progress transitioning our Beta 2. |
businesswire.com |
2024-03-04 18:10:00 |
Czytaj oryginał (ang.) |
| Vicarious Surgical to Participate in TD Cowen's 44th Annual Healthcare Conference |
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced the Company will participate in the TD Cowen 44th Annual Healthcare Conference. Management is scheduled to present on Tuesday, March 5, 2024 at 2:10 p.m. ET. A live webcast of the presentation will be accessible to th. |
businesswire.com |
2024-02-20 10:30:00 |
Czytaj oryginał (ang.) |
| Vicarious Surgical to Report Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024 |
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced it will report financial results for the fourth quarter and full year ended December 31, 2023 after the market closes on Monday, March 4, 2024. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time. Investor. |
businesswire.com |
2024-02-12 18:30:00 |
Czytaj oryginał (ang.) |
| Vicarious Surgical Strengthens Executive Team with Appointment of Randy Clark as Company President |
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced that Randy Clark has been appointed President effective today, January 29, 2024. As Vicarious Surgical prepares for its next phase of growth following the anticipated finalization of the Vicarious Surgical Version 1.0. |
businesswire.com |
2024-01-29 10:30:00 |
Czytaj oryginał (ang.) |
| Vicarious Surgical to Present at the Piper Sandler 35th Annual Healthcare Conference |
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced the Company will present at the Piper Sandler 35th Annual Healthcare Conference. Management is scheduled to participate in a fireside chat on Tuesday, November 28, 2023, at 9:00 am ET. Interested parties can access a. |
businesswire.com |
2023-11-15 10:30:00 |
Czytaj oryginał (ang.) |
| Vicarious Surgical Inc. (RBOT) Q3 2023 Earnings Call Transcript |
Vicarious Surgical Inc. (NYSE:RBOT ) Q3 2023 Earnings Conference Call November 13, 2023 4:30 PM ET Company Participants Kaitlyn Brosco - Investor Relations Adam Sachs - Chief Executive Officer Bill Kelly - Chief Financial Officer Conference Call Participants Ryan Zimmerman - BTIG Adam Maeder - Piper Sandler Josh Jennings - TD Cohen Caitlin Cronin - Canaccord Genuity Operator Good afternoon, and welcome to Vicarious Surgical's Third Quarter 2023 Earnings Conference Call. My name is Kate, and I'll be your operator for today's call. |
seekingalpha.com |
2023-11-13 22:05:06 |
Czytaj oryginał (ang.) |
| Vicarious Surgical Reports Third Quarter 2023 Financial Results |
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced financial results for the quarter ended September 30, 2023. Management will host a corresponding conference call at 4:30 p.m. ET today, November 13, 2023. “The third quarter brought several successes for our business,. |
businesswire.com |
2023-11-13 18:05:00 |
Czytaj oryginał (ang.) |
| Vicarious Surgical to Report Third Quarter 2023 Financial Results on November 13, 2023 |
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced it will report financial results for the third quarter ended September 30, 2023, after the market closes on November 13, 2023. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time. Investors interested in l. |
businesswire.com |
2023-10-26 13:00:00 |
Czytaj oryginał (ang.) |
| Vicarious Surgical Receives Continued Listing Standard Notice From NYSE |
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient outcomes as well as both the cost and efficiency of surgical procedures, today announced that on September 20, 2023, it received a notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) that it is not in compliance with Section 802.01C of the NYSE Listed Company Manual because the average clo. |
businesswire.com |
2023-09-22 21:00:00 |
Czytaj oryginał (ang.) |